Expand BBIO Menu
BBIO MENU

BBIO Stock Posts


Unusual Option Volume

BBIO Bridgebio Pharma70.80-1.78 (-2.5%)

Bridgebio Pharma trades 1,743 contracts. The highest volume is in the 17-Apr-26 100 calls, which is 41.2% above the current price.
Unusual Option Volume

BBIO Bridgebio Pharma70.14+0.07 (+0.1%)

Bridgebio Pharma trades 1,786 contracts. The highest volume is in the 17-Apr-26 65 puts.
Unusual Option Volume

BBIO Bridgebio Pharma74.56+8.92 (+13.6%)

Bridgebio Pharma trades 4,040 contracts. The company has the following event: Leerink Partners Global Healthcare Conference on Mar 10, 2026.
Upcoming Earnings

BBIO Bridgebio Pharma67.39-0.52 (-0.8%)

Bridgebio Pharma will report earnings after the market closes. View Calendar The market is expecting a ±12.6% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±4.9%. View Expected Move (Conf Call: Feb 24 4:30 PM)
Unusual Option Volume

BBIO Bridgebio Pharma68.89-1.83 (-2.6%)

Bridgebio Pharma trades 4,066 contracts. BBIO will report earnings on Feb 24, 2026.
Unusual Option Volume

BBIO Bridgebio Pharma79.18+5.85 (+8.0%)

Bridgebio Pharma trades 5,421 contracts. The company has the following event: BridgeBio Investor Call and Webcast to Discuss Phase 3 PROPEL 3 Results for Oral Infigratinib in Achondroplasia on Feb 12, 2026. News: BridgeBio Reports Positive Phase 3 Topline Results for Oral Infigratinib with the First Statistically Significant Improvements in Body Proportionality in Achondroplasia
Market Data Delayed 15 Minutes